5 March 2019 - Approaches used in France and Germany could help break deadlock.
The opposing sides in the long-running dispute over access to cystic fibrosis treatment Orkambi will come face-to-face at a public meeting on Thursday as a parliamentary inquiry gets under way.
Vertex’s CEO Jeff Leiden will fly into London from the US to appear at the House of Commons’ health and social care committee inquiry, and will follow directly after NHS England’s National Director of Specialised Commissioning, John Stewart, in facing tough questions from the panel of MPs about Orkambi access on the NHS.